After-Hours Stock Movers 05/17: (ULBI) (CNCE) (MBIO) Higher; (EVFM) (DM) (XONE) Lower (more...)

May 17, 2021 5:34 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

After-Hours Stock Movers:

Ultralife Corporation (NASDAQ: ULBI) 31% HIGHER; has received a firm-fixed price indefinite-delivery/indefinite-quantity contract from the U.S. Army for purchases of Conformal Wearable Batteries not to exceed $168 million during the three-year base award period with the potential for up to an additional $350 million should the six one-year option periods be exercised. The timing of deliveries and quantities are at the discretion of the U.S. Army, and include successful completion of First Article Testing demonstrating full compliance with the contractual product specifications and program requirements.

Evofem Biosciences, Inc. (NASDAQ: EVFM) 18% LOWER; announced that it intends to offer and sell in an underwritten public offering, subject to market and other conditions, shares of its common stock (or pre-funded warrants to purchase common stock in lieu of common stock) in an underwritten public offering. Each share of common stock or pre-funded warrant will be sold with a common warrant to purchase one share of common stock. The Company expects to grant the underwriter a 30-day option to purchase additional shares of its common stock and/or warrants to purchase shares of its common stock at the public offering price, less the underwriting discounts and commissions. All of the shares of common stock, pre-funded warrants and common warrants to be sold in the offering are to be offered by Evofem.

Desktop Metal (NYSE: DM) 13% LOWER; reported Q1 EPS of ($0.25), $0.13 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $11.3 million versus the consensus estimate of $9.42 million.

ExOne (NASDAQ: XONE) 9.6% LOWER; reported Q1 EPS of ($0.29), $0.08 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $13.02 million versus the consensus estimate of $14.31 million.

Sun Country Airlines Holdings, Inc. (NASDAQ: SNCY) 7% LOWER; announced the commencement of a proposed secondary public offering of 6,000,000 shares of its common stock by an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) 6.5% HIGHER; today announced that Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) has purchased the potential future milestones under the companies’ 2017 asset purchase agreement relating to VX-561 (deutivacaftor) for $32 million.

Mustang Bio (NASDAQ: MBIO) 6.3% HIGHER; BTIG initiates coverage on with a Buy rating and a price target of $11.00.

Adicet Bio (NASDAQ: ACET) 3.6% HIGHER; BTIG initiates coverage with a Buy rating and a price target of $34.00.

Clovis Oncology, Inc. (NASDAQ: CLVS) 3.2% LOWER; announced today that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (SEC), under which it may offer and sell, from time to time, shares of its common stock having an aggregate offering price of up to $75,000,000 million through an at-the-market equity offering program (the ATM Program). The timing and amount of any sales will be determined by a variety of factors considered by Clovis Oncology.

Coinbase Global, Inc. (Nasdaq: COIN) 2.9% LOWER; today announced its intention to offer, subject to market conditions and other factors, $1.25 billion aggregate principal amount of Convertible Senior Notes due 2026 (the notes) in a private offering (the offering) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act of 1933, as amended (the Securities Act).



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

After-Hours Movers, Pre-Open Losers, Pre-Open Winners, Equity Offerings, Pre Market Movers, BTIG